TRACON PHARMACEUTICALS INC (TCON) Stock News
NASDAQ:TCON - Nasdaq - US89237H3084 - Common Stock - Currency: USD
TCON Latest News, Press Relases and Analysis
TCON Stock Earnings: TRACON Pharma Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TRACON Pharma (NASDAQ:TCON) just reported results for the second quarter of 202...
TCON Stock Earnings: TRACON Pharma Beats EPS for Q2 2024
TCON stock results show that TRACON Pharma beat analyst estimates for earnings per share the second quarter of 2024.
TRACON Pharmaceuticals Announces it Will Wind Down Operations
TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform
The objective response rate by blinded independent central review in the fully enrolled ENVASARC pivotal trial in the 82 evaluable patients is 5% (four...
TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform
TCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TRACON Pharma (NASDAQ:TCON) just reported results for the first quarter of 2024...
TCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024
TCON stock results show that TRACON Pharma missed analyst estimates for earnings per share the first quarter of 2024.
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients
Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with...
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
Explore three penny stocks primed for significant growth, backed by Strong Buy ratings from Wall Street. Play it high-risk.
TRACON Pharmaceuticals Announces Reverse Stock Split
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a...
TRACON Pharmaceuticals Announces Reverse Stock Split
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!